Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

$1.5m funding for breast cancer project:

This article was originally published in Clinica

Executive Summary

An investigation into new ways to detect breast cancer is underway with joint funding of $1.5 million from Hyal Pharmaceutical and the Natural Sciences and Engineering Research Council of Canada. Researchers at McMaster University, the University of Toronto and the Toronto Hospital, will attempt to find out if hyaluronic acid used with MRI in mammography will result in more reliable detection of early-stage breast cancer. Hyaluronic acid binds to breast cancer cells and will be used as a carrier for MRI imaging agents.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086505

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel